Paresthesia: The Numbing and Tingling Sensations of Benzodiazepine Withdrawal

Benzodiazepines are a class of psychoactive drugs commonly prescribed for conditions such as anxiety, insomnia, and seizures. When patients who have taken a benzodiazepine for an extended period of time stop suddenly or reduce the dose too quickly, they may experience a range of withdrawal symptoms, including paresthesia. Paresthesia is characterized by abnormal sensations such as tingling, numbness, burning, or prickling, which can occur in various parts of the body. These sensations can be distressing and uncomfortable, and they add to the overall discomfort of benzodiazepine withdrawal.

Paresthesia occurs during benzodiazepine withdrawal because of the drug’s effect on the central nervous system. Benzodiazepines act on the gamma-aminobutyric acid (GABA) receptors in the brain, which inhibit the transmission of nerve signals. After long-term use, the brain adapts to the drug and the GABA system becomes less responsive. When the benzodiazepine is then stopped or reduced abruptly, that weakened inhibition can no longer hold the nervous system in check, and the result is a state of hyperexcitability. This hyperexcitability can manifest as abnormal sensations such as paresthesia. Patients going through benzodiazepine withdrawal should know that paresthesia is a common symptom and that it is typically temporary, although for some patients it can persist, coming and going, into protracted withdrawal. A safe tapering plan, with medical support, is the most effective way to manage paresthesia and other withdrawal symptoms.

This kind of withdrawal is a consequence of physical dependence on a prescribed medication, and dependence is not addiction. It calls for a gradual medical taper, not an addiction program.

The Effects of Benzodiazepine Withdrawal on the Nervous System

Benzodiazepine withdrawal can have profound effects on the nervous system, leading to a range of physical and psychological symptoms. The sudden discontinuation or reduction of a benzodiazepine disrupts the balance of neurotransmitters in the brain, leading to hyperexcitability and overactivity in the central nervous system. This can result in symptoms such as anxiety, insomnia, tremors, muscle spasms, and paresthesia. The nervous system may also become hypersensitive during withdrawal, leading to an increased perception of pain and discomfort.

In addition to these acute effects, long-term benzodiazepine use and subsequent withdrawal involve neuroadaptive changes in the brain. Prolonged exposure to a benzodiazepine leads to downregulation of GABA receptors and changes in other neurotransmitter systems, which result in tolerance, dependence, and withdrawal symptoms. These neuroadaptive changes contribute to the severity and duration of benzodiazepine withdrawal symptoms, including paresthesia. Patients going through benzodiazepine withdrawal should be aware of these effects on the nervous system and seek medical support to ensure a safe and effective tapering process.

The Ashton Manual: A Safe Approach to Benzodiazepine Tapering

The Ashton Manual, written by Professor C. Heather Ashton, is a widely recognized approach to benzodiazepine tapering that emphasizes slow and gradual reduction of the dose to minimize withdrawal symptoms. For patients taking a short-acting benzodiazepine such as alprazolam or lorazepam, the Manual advises a crossover taper to a longer-acting one, diazepam, before the reductions begin, so that the blood level of the drug falls smoothly instead of swinging between doses. The dose is then reduced in steps of up to one tenth of the current dose, and often smaller, at a pace the patient can tolerate, with the whole process taking months and often a year or more. This slow approach allows the nervous system to adjust gradually to lower levels of the drug, minimizing the risk of severe withdrawal symptoms such as paresthesia. Patients on diazepam itself can read more about tapering off Valium.

The Ashton Manual also emphasizes the importance of individualized tapering plans based on the specific needs and responses of each person. It recognizes that there is no one-size-fits-all solution to benzodiazepine withdrawal and that the tapering process should be tailored to each patient’s circumstances. By following the Ashton Manual under the guidance of a knowledgeable physician, patients can minimize the risk of paresthesia and other distressing withdrawal symptoms while safely discontinuing their benzodiazepine.

The Maudsley Deprescribing Guidelines: A Framework for Benzodiazepine Withdrawal

The Maudsley Deprescribing Guidelines provide a framework for safely reducing or discontinuing a benzodiazepine. The guidelines emphasize shared decision-making between the patient and the prescriber, taking into account the patient’s preferences, needs, and circumstances. The Maudsley approach, like the Ashton Manual, calls for gradual tapering to minimize withdrawal symptoms such as paresthesia.

In addition to guidance on tapering schedules and dose reductions, the Maudsley Deprescribing Guidelines emphasize ongoing monitoring and support throughout the taper. For the patient, this means regular check-ins about withdrawal symptoms and a prescriber who is willing to slow the taper, or hold the dose, when symptoms such as paresthesia flare. Under this approach, the patient’s experience sets the pace.

Finding a Deprescribing Doctor: The Importance of Medical Support in Benzodiazepine Withdrawal

Finding a physician who is knowledgeable about benzodiazepine deprescribing matters a great deal for a patient facing withdrawal symptoms such as paresthesia. A deprescribing doctor develops a personalized tapering plan based on the patient’s needs and responses, monitors symptoms throughout the process, and adjusts the pace when the nervous system needs more time.

Dr. Leeds is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, and his practice provides medically supervised benzodiazepine tapering for patients in Florida. He works from the Ashton Manual and the Maudsley Deprescribing Guidelines, and the plan is set with the patient, not for the patient. When paresthesia or other symptoms flare after a reduction, the answer is usually to hold or to slow down, and that decision is made together. The practice’s contact form is the first step for a patient who wants to discuss a taper.

Coping with Paresthesia During Benzodiazepine Withdrawal: Tips and Strategies

Coping with paresthesia during benzodiazepine withdrawal can be challenging, but there are several strategies that patients can use to manage these sensations. Relaxation techniques such as deep breathing, meditation, or progressive muscle relaxation can reduce the anxiety and discomfort that come with paresthesia. Distraction techniques such as listening to music, engaging in hobbies, or spending time with loved ones can also shift attention away from the sensations. Gentle movement, a warm bath, or light massage of the affected area gives some patients relief.

It is important for a patient experiencing paresthesia to communicate openly with the prescriber about the symptom. The most reliable relief is usually a slower taper, or a hold at the current dose, rather than a treatment aimed at the sensation itself. Support from friends and family members can provide emotional comfort and validation during this time. One caution: numbness or weakness that comes on suddenly on one side of the body, trouble speaking, or a seizure is a medical emergency, and the right response is to call emergency services.

Seeking Support: Resources for Individuals Going Through Benzodiazepine Withdrawal

For patients going through benzodiazepine withdrawal, reliable support makes symptoms such as paresthesia easier to bear. With a physician’s tapering plan in place, hearing from others who have felt the same sensations and come out the other side can offer reassurance that the symptom is a known part of withdrawal, so long as that reassurance never replaces the prescriber’s guidance on the taper itself.

The most important resource is medical: a physician who understands benzodiazepine dependence, who can develop a personalized tapering plan, and who monitors the patient throughout the process. With that support in place, patients can get through benzodiazepine withdrawal with greater confidence.

Dr. Leeds’ practice in Fort Lauderdale, Florida, helps patients taper off benzodiazepines gradually, under medical supervision, at a pace their nervous system can tolerate. Paresthesia and the other sensory symptoms of withdrawal are expected, temporary in most cases, and manageable with a slow taper. For patients in Florida who want to discuss a supervised taper, Contact Dr. Leeds.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.